General Head and Neck Cancer

Long term Follow up Confirms Success of MGH-developed Laser Treatment for Vocal-cord Cancer (12-19-2014)

More than three years after pulsed-KTP laser treatment, 96 percent of patients with early vocal-cord tumors are cancer-free. The first long-term study of a pioneering endoscopic laser treatment for early vocal-cord cancer,  developed at Massachusetts... Continue Reading

USPSTF Issues Final Recommendation on Oral Cancer Screening (12-18-2013)

The U.S. Preventive Services Task Force (USPSTF) has released its final recommendation regarding screening for oral cancer. The task force issued an “I” statement, which means there is not enough evidence to make a definitive recommendation for or... Continue Reading

Swallowing Exercises and Oral Nutrition Are Critical During Treatment for Oral Cancer (10-7-2013)

Patients with oral cancers who receive oral nutrition and practice swallowing exercises throughout their treatment are able to maintain a significantly better long-term diet, according to the results of a study published in JAMA Otolaryngology Head and... Continue Reading

Adding Vectibix to Cisplatin/Fluorouracil Improves Progression-Free Survival in Recurrent or Metastatic Head and Neck Cancer (08-2-2013)

The addition of Vectibix® (panitumumab) to cisplatin/fluorouracil as first-line treatment improves progression-free survival in patients with recurrent or metastatic head and neck cancer, according to the results of a study published in The Lancet Oncology. Head... Continue Reading

Doxepin Reduces Mouth Pain from Radiation for Head and Neck Cancer (11-14-2012)

The tricyclic antidepressant doxepin reduces oral mucositis in patients who receive radiation for head and neck cancer, according to the results of a study presented at the 54th annual meeting of the American Society for Radiation Oncology in Boston,... Continue Reading

Aspirin Continues to Look Promising for Cancer Prevention (03-26-2012)

A combined analysis of 51 randomized trials found that daily aspirin use reduces the risk of new cancer diagnoses as well as the risk of cancer death. These results were published in The Lancet. A growing body of evidence suggests that aspirin may reduce... Continue Reading

Combined Treatment Provides Benefit for Nasopharyngeal Cancer (02-22-2012)

Among patients with Stage II nasopharyngeal cancer (a type of head and neck cancer), adding chemotherapy to radiation therapy resulted in better survival than radiation therapy alone. These results were published in the Journal of the National Cancer... Continue Reading

Erbitux Approved for New Use in Head and Neck Cancer (11-18-2011)

The US Food and Drug Administration has expanded the approval of Erbitux® (cetuximab) to include the initial treatment, in combination with platinum-based chemotherapy, of selected patients with recurrent or metastatic squamous cell head and neck cancer. Head... Continue Reading

HPV Vaccine Recommended for Boys (11-1-2011)

The Advisory Committee on Immunization Practices of the U.S. Centers for Disease Control and Prevention (CDC) has recommended that boys be vaccinated against human papillomavirus (HPV). Human papillomaviruses (HPV) consist of more than 100 different viruses.... Continue Reading

Laser Therapy Reduces Oral Mucositis in Head and Neck Cancer (08-18-2011)

The use of low-level laser therapy (LLLT) may reduce the incidence and severity of oral mucositis caused by chemotherapy and/or radiation therapy among patients with head and neck cancer. These results were presented at the 2011 annual meeting of the... Continue Reading

« Previous PageNext Page »